Mr. Laurence Harewood
Honorary
Surgery - Royal Melbourne Hospital
17 Scholarly works
0 Projects
HIGHLIGHTS
2020
Journal article
Use of prostate-specific membrane antigen positron-emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer
DOI: 10.1111/bju.151512019
Conference Proceedings
Use of PSMA PET/CT to Assess Treatment Response Following Upfront Chemohormonal Therapy in Metastatic Prostate Cancer (MPC)
2018
Conference Proceedings
Using PSMA PET/CT to assess response in metastatic prostate cancer (mPC) patients (pts) receiving upfront chemohormonal therapy
DOI: 10.1093/annonc/mdy434.0112018
Journal article
Patient-derived Models of Abiraterone- and Enzalutamide-resistant Prostate Cancer Reveal Sensitivity to Ribosome-directed Therapy
DOI: 10.1016/j.eururo.2018.06.0202017
Journal article
Multiparametric magnetic resonance imaging for prostate cancer-a comparative study including radical prostatectomy specimens
DOI: 10.1007/s00345-016-1960-x2016
Journal article
Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression
DOI: 10.18632/oncotarget.89152015
Journal article
Does perineural invasion in a radical prostatectomy specimen predict biochemical recurrence in men with prostate cancer?
DOI: 10.5489/cuaj.2619
RECENT SCHOLARLY WORKS
2015
Journal article
Assessing expression of MUC1 and ZAG protein biomarkers in prostate biopsies improves prediction of adverse pathology following radical prostatectomy
DOI: 10.2174/18768229015080100012013
Journal article
Presence or absence of a positive pathological margin outperforms any other margin-associated variable in predicting clinically relevant biochemical recurrence in Gleason 7 prostate cancer
DOI: 10.1111/j.1464-410X.2012.11665.x2012
Journal article
Re-evaluating the biological significance of seminal vesicle invasion (SVI) in locally advanced prostate cancer
DOI: 10.1111/j.1464-410X.2012.11477.x